GlassScriptPhysician profile
Maurice D Weiss
NPI 1659350882
$12,431.01
in general payments reported to CMS, 2019-2025
46 companies · $1,104 in 2025
The $1,104 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,654 · 2020: $1,659 · 2021: $2,307 · 2022: $2,012 · 2023: $2,034 · 2024: $1,661 · 2025: $1,104.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,767 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,767.32 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $2,450.13 | 2019-2025 | |
| Abbott Laboratories | $1,481.11 | 2019-2025 | Mitraclip, Aveir, Cardiomems |
| Astrazeneca Pharmaceuticals LP | $1,041.15 | 2019-2025 | Brilinta, Farxiga |
| Janssen Pharmaceuticals, INC | $969.58 | 2019-2024 | Xarelto |
| Amgen INC. | $777.31 | 2019-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $614.43 | 2019-2025 | Camzyos, Eliquis |
| Merck Sharp & Dohme LLC | $531.88 | 2021-2025 | Verquvo |
| Novo Nordisk INC | $506.99 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Amarin Pharma, INC. | $412.10 | 2019-2022 | |
| Pfizer INC. | $379.73 | 2019-2025 | |
| Kowa Pharmaceuticals America, INC. | $375.37 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $356.13 | 2019-2024 | Jardiance |
| Sanofi-Aventis U.S. LLC | $320.48 | 2019-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $304.80 | 2019-2025 | Lifevest |
| Cvrx, INC. | $295.82 | 2022-2024 | Barostim Neo System |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $185.70 | 2024-2025 | |
| Boston Scientific Corporation | $160.12 | 2019-2025 | Watchman Flx, Watchman Access System |
| W. L. Gore & Associates, INC. | $125.57 | 2020-2024 | Gore Cardioform Septal Occluder |
| Biotronik INC. | $125.44 | 2025 | Biomonitor |
| Alnylam Pharmaceuticals INC. | $119.69 | 2019-2025 | Onpattro, Amvuttra |
| Regeneron Healthcare Solutions, INC. | $75.24 | 2019-2024 | Evkeeza |
| Tactile Systems Technology INC | $75.12 | 2020-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Esperion Therapeutics, INC. | $70.68 | 2020-2024 | Nexletol |
| Kiniksa Pharmaceuticals, LTD. | $66.47 | 2021-2023 | Arcalyst |
| Bayer Healthcare Pharmaceuticals INC. | $59.40 | 2021-2025 | |
| Catheter Precision INC. | $52.87 | 2023 | |
| Scpharmaceuticals INC. | $49.18 | 2024-2025 | |
| Atricure, INC. | $47.02 | 2024-2025 | Atriclip Laa Exclusion System |
| Abiomed | $39.84 | 2022 | |
| Edwards Lifesciences Corporation | $36.39 | 2024-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Biosense Webster, INC. | $36.11 | 2019 | |
| Kiniksa Pharmaceuticals International, Plc | $34.46 | 2024 | Arcalyst |
| Actelion Pharmaceuticals US, INC. | $31.67 | 2024 | Opsumit, Uptravi |
| Chiesi USA, INC. | $27.88 | 2019 | |
| Baxter Healthcare | $22.36 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Globus Medical, INC. | $19.49 | 2025 | Senza |
| Lexicon Pharmaceuticals, INC. | $18.99 | 2023 | Inpefa |
| Glaxosmithkline, LLC. | $18.61 | 2025 | Arexvy, Shingrix |
| Potrero Medical, INC. | $17.12 | 2023 | |
| Medtronic Vascular, INC. | $15.98 | 2020 | |
| Angiodynamics, INC. | $14.23 | 2021 | |
| Akcea Therapeutics, INC. | $14.14 | 2020 | |
| Bridgebio Pharma, INC. | $13.97 | 2025 | Attruby |
| Impulse Dynamics (USA) INC. | $13.85 | 2023 | Optimizer |
| Medicure Pharma INC. | $13.65 | 2021 | |
| Medtronic, INC. | $12.76 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maurice Weiss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.